CD44: A cancer stem cell-related biomarker with predictive potential for radiotherapy
Research output: Contribution to journal › Comment/Debate › Contributed › peer-review
Contributors
Abstract
CD44, a cancer stem cell (CSC)-related surface marker, correlates with local control after radiotherapy of early laryngeal cancer. For the first time, a CSC-related marker has been functionally validated for radiotherapy in patients. CD44 expression bears the potential to predict the outcome of radiotherapy by assessment of CSC density.
Details
| Original language | English |
|---|---|
| Pages (from-to) | 5091-5093 |
| Number of pages | 3 |
| Journal | Clinical cancer research |
| Volume | 16 |
| Issue number | 21 |
| Publication status | Published - 1 Nov 2010 |
| Peer-reviewed | Yes |
External IDs
| PubMed | 20861165 |
|---|---|
| ORCID | /0000-0003-1776-9556/work/171065839 |